Related Experiment Videos
Inverse correlation between Skp2 and p27(Kip1) in normal endometrium and endometrial carcinoma
Tsutomu Miyamoto1, Akiko Horiuchi, Hiroyasu Kashima
1Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan.
Abstract:
Cyclin-dependent-kinase (cdk) inhibitor, p27(Kip1) (p27), has been shown to participate in progestin-induced growth suppression of normal endometrial glands. To analyse the molecular mechanisms regulating p27 protein, we examined immunohistochemical expression of the SCF(Skp2) (Skp1-Cullin-F-box protein) complex factors, i.e. Skp1, Cul1 and Skp2, and compared them with that of p27, steroid receptors and Ki-67. In normal endometrial glands, the expression of Skp2 was observed in the proliferative phase, whereas that of p27 was observed in the secretory phase. Cultured normal endometrial glandular cells showed that progesterone induced the down-regulation of Skp2 along with up-regulation of p27. In endometrial carcinomas, the inverse topological correlation between Skp2 and p27 was evident in 39/66 (59%) cases, and the expression of Skp2 showed a strong correlation with Ki-67. These findings suggest that the expression of SCF(Skp2) complex changes during the menstrual cycle in normal endometrium and the SCF(Skp2) ubiquitin-proteasome pathway may also work in endometrial carcinomas.
Insights
The SCF(Skp2) complex regulates p27 protein levels in the endometrium. Its expression changes with the menstrual cycle and may be involved in endometrial cancer progression.
Area of Science:
- Gynecologic Oncology
- Cellular and Molecular Biology
- Endocrinology
Background:
- p27(Kip1) (p27) is a cyclin-dependent kinase inhibitor involved in progestin-induced growth suppression in normal endometrial glands.
- The SCF(Skp2) complex, comprising Skp1, Cullin1, and Skp2, is a key regulator of p27 protein degradation via the ubiquitin-proteasome pathway.
Purpose of the Study:
- To investigate the molecular mechanisms regulating p27 protein expression in the endometrium.
- To analyze the expression of SCF(Skp2) complex factors (Skp1, Cul1, Skp2) in relation to p27, steroid receptors, and Ki-67 in normal and cancerous endometrial tissues.
Main Methods:
- Immunohistochemical analysis of Skp1, Cul1, Skp2, p27, steroid receptors, and Ki-67 expression.
- Examination of cultured normal endometrial glandular cells treated with progesterone.
Main Results:
- In normal endometrium, Skp2 expression peaked in the proliferative phase, while p27 expression was highest in the secretory phase.
- Progesterone treatment of cultured endometrial cells led to decreased Skp2 and increased p27 expression.
- An inverse correlation between Skp2 and p27 expression was observed in 59% of endometrial carcinomas.
- Skp2 expression strongly correlated with Ki-67, a marker of cell proliferation, in endometrial carcinomas.
Conclusions:
- SCF(Skp2) complex expression exhibits dynamic changes throughout the menstrual cycle in normal endometrium.
- The SCF(Skp2) ubiquitin-proteasome pathway is implicated in the regulation of p27 and may play a role in the pathogenesis of endometrial carcinomas.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity